PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
116.11%
Positive net income growth while Healthcare median is negative at -5.59%. Peter Lynch would view it as a strong advantage vs. struggling peers.
21.06%
D&A growth of 21.06% while Healthcare median is zero at 0.00%. Walter Schloss would question intangible or new expansions driving that cost difference.
530.30%
Deferred tax growth of 530.30% while Healthcare median is zero at 0.00%. Walter Schloss would see a difference that might matter for future cash flow if significant.
-187.47%
SBC declines yoy while Healthcare median is 0.00%. Seth Klarman would see a near-term advantage in less dilution unless new hires are needed.
-193.28%
Working capital is shrinking yoy while Healthcare median is 0.00%. Seth Klarman would see an advantage if sales remain robust.
-164.72%
AR shrinks yoy while Healthcare median is 0.00%. Seth Klarman would see an advantage in working capital if sales do not drop.
-1036.63%
Inventory shrinks yoy while Healthcare median is 0.00%. Seth Klarman would see a working capital edge if sales hold up.
205.25%
AP growth of 205.25% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or credit policies affecting the difference.
-267.07%
Other WC usage shrinks yoy while Healthcare median is 0.00%. Seth Klarman would see an advantage if top-line is stable or growing.
-111.49%
Other non-cash items dropping yoy while Healthcare median is 0.00%. Seth Klarman would see a short-term advantage if real fundamentals remain intact.
9996.05%
CFO growth of 9996.05% while Healthcare median is zero at 0.00%. Walter Schloss would see a small edge that may compound with consistent execution.
-30.06%
CapEx declines yoy while Healthcare median is 0.00%. Seth Klarman would note a short-term FCF advantage if revenue is stable.
2410.18%
Acquisition growth of 2410.18% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or partial deals fueling that difference.
48.73%
Purchases growth of 48.73% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or new strategic positions driving the difference.
-95.97%
We liquidate less yoy while Healthcare median is 0.00%. Seth Klarman would see a firm-specific hold strategy unless missed gains exist.
5928.18%
Growth of 5928.18% while Healthcare median is zero at 0.00%. Walter Schloss questions intangible or special projects explaining that difference.
2602.75%
Investing flow of 2602.75% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or deals prompting that difference.
-1408.93%
Debt repayment yoy declines while Healthcare median is 0.00%. Seth Klarman fears increased leverage if expansions do not yield quick returns.
30700.49%
Issuance growth of 30700.49% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or acquisitions financed by new shares.
No Data
No Data available this quarter, please select a different quarter.